Recent updates on Colgate-Palmolive (CL) include a mixture of analysis and predictions by investment experts.
Jim Cramer noted CL as a stock facing pressure while Stifel Nicolaus and Barclays issued pessimistic forecasts for the stock price. Deutsche Bank, Stifel, and JPMorgan Chase & Co. have subsequently
lowered PT for the stock.
Despite these concerns, some see CL as a potentially good choice for dividend investment with Boston Common Asset Management LLC and Avanza Fonder AB deciding to
purchase shares. Other asset management companies including Sax Wealth Advisors LLC, Rockland Trust Co., Ritholtz Wealth Management, and Assenagon Asset Management S.A. have also increased their holdings in CL.
There are mixed signals from insiders, who sold US$3.5m in stock, possibly indicating potential weakness.
Colgate-Palmolive has further announced its Q4 & Full Year 2024 earnings and
Webcasts of its 2024 third quarter earnings conference call. The company also announced a $0.50
quarterly payout extending its 129-year dividend streak and raising its annual revenue growth outlook.
Despite some stock market losses, performance on strong trading days has seen CL outperform competitors.
Colgate-Palmolive Company CL News Analytics from Wed, 08 May 2024 07:00:00 GMT to Sat, 18 Jan 2025 16:49:31 GMT -
Rating 0
- Innovation -3
- Information 3
- Rumor -6
